BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6441303)

  • 21. Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants.
    Denis-Magdelaine A; Flahault A; Verdy E
    Haemostasis; 1995; 25(3):98-105. PubMed ID: 7607585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lupus-type anticoagulants and thromboses].
    Sultan Y
    Ann Med Interne (Paris); 1986; 137(6):475-6. PubMed ID: 3101565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus anticoagulants.
    Shapiro SS; Thiagarajan P
    Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
    [No Abstract]   [Full Text] [Related]  

  • 24. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
    Nybo M; Dieperink H; Kristensen SR
    Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Screening method of lupus anticoagulants using coagulation technics: clinical application to patients with SLE and habitual abortion].
    Motoi S; Suehisa E; Nishimura K; Amino N; Miyai K; Mori M; Tanizawa O
    Rinsho Byori; 1988 Jan; 36(1):71-6. PubMed ID: 3130514
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S; Gorgi Y; Ayed K; Dellagi K
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
    Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
    Thromb Haemost; 2000 May; 83(5):704-8. PubMed ID: 10823266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of lupus-like anticoagulants by an enzyme-linked immunosorbent assay using a partial thromboplastin as antigen; a comparative study.
    Arnout J; Huybrechts E; Vanrusselt M; Falcon C; Vermylen J
    Thromb Haemost; 1990 Aug; 64(1):26-31. PubMed ID: 2125756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulating anticoagulants and pregnancy: a risky combination].
    Dantal J; Dantal F; Sagot P; Lopes P; Lerat MF
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):317-24. PubMed ID: 3135300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate.
    Alving BM; Banerji B; Fogler WE; Alving CR
    Clin Exp Immunol; 1987 Aug; 69(2):403-8. PubMed ID: 2820640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated partial thromboplastin time reagents: an evaluation.
    Howarth S
    Br J Biomed Sci; 1993 Jun; 50(2):109-13. PubMed ID: 8219915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Presentation of 20 cases of lupus anticoagulant. Proposal for a methodology for its study].
    Mompel Sanjuán A; Abad Gosalbez A; García Pérez A; Marco Vera P
    Sangre (Barc); 1988 Aug; 33(4):306-9. PubMed ID: 3142061
    [No Abstract]   [Full Text] [Related]  

  • 34. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of various anticoagulants on blood coagulation: with special reference to false positive lupus anticoagulants].
    Onda H; Watanabe H
    Rinsho Byori; 1989 Dec; 37(12):1385-91. PubMed ID: 2515325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids.
    Rauch J; Tannenbaum M; Janoff AS
    Thromb Haemost; 1989 Nov; 62(3):892-6. PubMed ID: 2512678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
    Brandt JT; Triplett DA
    Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
    Okuda M; Yamamoto Y
    Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reliability of activated partial thromboplastin time methods and the relationship to lipid composition and ultrastructure.
    Stevenson KJ; Easton AC; Curry A; Thomson JM; Poller L
    Thromb Haemost; 1986 Apr; 55(2):250-8. PubMed ID: 3715790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.